Deutsche Bank Initiates AMAG Pharmaceuticals With Hold

Analysts at Deutsche Bank initiated coverage on

with a Hold rating. The target price for AMAG Pharmaceuticals is set to $75. AMAG Pharmaceuticals shares have gained 257.22 percent over the past 52 weeks, while the S&P 500 index has surged 8.92 percent in the same period. AMAG Pharmaceuticals' shares fell 0.29 percent to close at $68.98 yesterday.